Ultragenyx Pharmaceutical Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

RARE
Ultragenyx Pharmaceutical

Last Price:

$34.90

Seasonality Move:

10.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Ultragenyx Pharmaceutical Stock Forecast

Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 5.9% based on the past 11 years of stock performance.
Ultragenyx Pharmaceutical has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Is Ultragenyx Pharmaceutical Stock Undervalued?

The current Ultragenyx Pharmaceutical [RARE] share price is $34.14. The Score for RARE is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Ultragenyx Pharmaceutical Stock Go Up Next Year?

Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 5.9% based on the past 11 years of stock performance.

Ultragenyx Pharmaceutical Stock Rating

Sell

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical overpriced?

Ultragenyx Pharmaceutical has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Ultragenyx Pharmaceutical Stock Price History

Is RARE stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

ultragenyx.com

52-Week Data

52-Week High:

60.37

52-Week Low:

29.59

Prediction Charts

Market Cap:

3.2B

Price in USD:

34.14

Volume:

1.1M

Beta:

1.12

Technical Analysis

SMA50:

39.97

SMA100:

42.36

SMA200:

46.69

52-Wk Change:

-32.66%

Stock Predictions

Is Ultragenyx Pharmaceutical stock public?

Yes, Ultragenyx Pharmaceutical is a publicly traded company.
What is the Ultragenyx Pharmaceutical stock quote today?

The Ultragenyx Pharmaceutical stock price is 34.14 USD today.
How to buy Ultragenyx Pharmaceutical stock online?

You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-25	39.19	38.69	39.19	38.12
Mar-26	38.77	37.98	38.77	36.71
Mar-27	38.44	38.89	39.21	37.98
Mar-28	38.64	37.82	38.76	37.70
Mar-31	36.91	36.21	36.98	35.53
Apr-1	36.06	33.84	36.25	33.69
Apr-2	33.53	35.37	35.42	33.53
Apr-3	34.35	35.13	35.47	34.29
Apr-4	34.32	32.43	34.79	32.07
Apr-7	30.99	32.14	33.35	30.46
Apr-8	32.95	31.06	34.15	30.15
Apr-9	30.18	33.91	34.49	29.59
Apr-10	33.22	33.16	33.62	31.36
Apr-11	33.17	34.14	34.50	32.41

Ultragenyx Pharmaceutical Earnings

Ultragenyx Pharmaceutical Earnings Report: Per Share Ultragenyx Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ultragenyx Pharmaceutical Forecast Revenue Growth

Ultragenyx Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Ultragenyx Pharmaceutical and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.81 per share, and an increase next year of $1.90 per share.

* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.